Loading…
Lobbying Spend
—
Filings
16
Firms Hired
1
Active Period
2017–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Increasing Prescription Drug Competition Act
2024 · first_quarter · Firm: THE MCMANUS GROUP
Increased access to narcoleptic medication (S.574/H.R.4692 - Increasing Prescription Drug Competition Act)
Client expense: — · Firm income: $40,000
Matched citations: H.R.4692
Increasing Prescription Drug Competition Act
2024 · first_quarter · Firm: THE MCMANUS GROUP
Increased access to narcoleptic medication (S.574/H.R.4692 - Increasing Prescription Drug Competition Act)
Client expense: — · Firm income: $40,000
Matched citations: S.574
Increasing Prescription Drug Competition Act
2023 · fourth_quarter · Firm: THE MCMANUS GROUP
Increased access to narcoleptic medication (S.574/H.R.4692 - Increasing Prescription Drug Competition Act)
Client expense: — · Firm income: $60,000
Matched citations: H.R.4692
Increasing Prescription Drug Competition Act
2023 · fourth_quarter · Firm: THE MCMANUS GROUP
Increased access to narcoleptic medication (S.574/H.R.4692 - Increasing Prescription Drug Competition Act)
Client expense: — · Firm income: $60,000
Matched citations: S.574
Increasing Prescription Drug Competition Act
2023 · third_quarter · Firm: THE MCMANUS GROUP
Increased access to narcoleptic medication (S.574/H.R.4692 - Increasing Prescription Drug Competition Act)
Client expense: — · Firm income: $60,000
Matched citations: H.R.4692
Increasing Prescription Drug Competition Act
2023 · third_quarter · Firm: THE MCMANUS GROUP
Increased access to narcoleptic medication (S.574/H.R.4692 - Increasing Prescription Drug Competition Act)
Client expense: — · Firm income: $60,000
Matched citations: S.574
Increasing Prescription Drug Competition Act
2023 · second_quarter · Firm: THE MCMANUS GROUP
Increased access to narcoleptic medication (S.574 - Increasing Prescription Drug Competition Act)
Client expense: — · Firm income: $60,000
Matched citations: S.574
Increasing Prescription Drug Competition Act
2023 · first_quarter · Firm: THE MCMANUS GROUP
Increased access to narcoleptic medication (S.574 - Increasing Prescription Drug Competition Act)
Client expense: — · Firm income: $50,000
Matched citations: S.574
Increasing Prescription Drug Competition Act
2022 · fourth_quarter · Firm: THE MCMANUS GROUP
Increased access to narcoleptic medication (S.4918 - Increasing Prescription Drug Competition Act)
Client expense: — · Firm income: $50,000
Matched citations: S.4918
Increasing Prescription Drug Competition Act
2022 · third_quarter · Firm: THE MCMANUS GROUP
Increased access to narcoleptic medication (S.4918 - Increasing Prescription Drug Competition Act)
Client expense: — · Firm income: $50,000
Matched citations: S.4918
Source: Senate LDA